Review
doi: 10.1007/BF01726444.
Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides
Affiliations
- PMID: 1816107
- DOI: 10.1007/BF01726444
Item in Clipboard
Review
Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides
Infection.
1991 Nov-Dec.
No abstract available
Similar articles
-
Possibilities of immunoprophylaxis and immunotherapy in gut-derived infectious-toxic shock (GITS).Curr Stud Hematol Blood Transfus. 1992;(59):301-23. doi: 10.1159/000429615. Curr Stud Hematol Blood Transfus. 1992. PMID: 1572217 Review. No abstract available.
-
Endotoxin-based molecular strategies for the prevention and treatment of gram-negative sepsis and septic shock.Curr Top Microbiol Immunol. 1996;216:275-97. doi: 10.1007/978-3-642-80186-0_13. Curr Top Microbiol Immunol. 1996. PMID: 8791745 Review. No abstract available.
-
Adoptive immunotherapy of gram-negative sepsis: use of monoclonal antibodies to lipopolysaccharide.Crit Care Med. 1993 Feb;21(2 Suppl):S32-9. doi: 10.1097/00003246-199302001-00007. Crit Care Med. 1993. PMID: 8428494 Review.
-
Immunotherapy with antibodies to core lipopolysaccharide: a critical appraisal.Infect Dis Clin North Am. 1991 Dec;5(4):915-27. Infect Dis Clin North Am. 1991. PMID: 1723740 Review.
-
Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.Prog Clin Biol Res. 1991;367:141-59. Prog Clin Biol Res. 1991. PMID: 1924424 Review.
Cited by
-
Bactericidal monoclonal antibody against Moraxella catarrhalis lipooligosaccharide cross-reacts with Haemophilus Spp.Curr Microbiol. 2007 Feb;54(2):85-90. doi: 10.1007/s00284-005-0463-6. Epub 2007 Jan 5. Curr Microbiol. 2007. PMID: 17211546
-
Enhanced protection by use of a combination of anticapsule and antilipopolysaccharide monoclonal antibodies against lethal Escherichia coli O18K5 infection of mice.Infect Immun. 1996 Mar;64(3):775-81. doi: 10.1128/iai.64.3.775-781.1996. Infect Immun. 1996. PMID: 8641781 Free PMC article.
-
Improving Immunotherapy Through Glycodesign.Front Immunol. 2018 Nov 2;9:2485. doi: 10.3389/fimmu.2018.02485. eCollection 2018. Front Immunol. 2018. PMID: 30450094 Free PMC article. Review.
-
Cross-reactivity of monoclonal antibodies and sera directed against lipid A and lipopolysaccharides.Infection. 1993 May-Jun;21(3):179-86. doi: 10.1007/BF01710544. Infection. 1993. PMID: 8365817